Xtant Book Value Per Share from 2010 to 2025

XTNT Stock

USD 0.50 0.02 3.45%

Xtant Medical Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Xtant Medical Holdings according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

0.32142278

Current Value

0.34

Quarterly Volatility

12.26157481

Credit Downgrade

Yuan Drop

Covid

Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 123.1 M or Gross Profit of 36.4 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0 or PTB Ratio of 1.31. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.

Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Xtant Medical Holdings over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Xtant Medical's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.31 X

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Xtant Book Value Per Share Regression Statistics

	Arithmetic Mean	(2.28)
	Geometric Mean	2.06
	Coefficient Of Variation	(538.69)
	Mean Deviation	7.77
	Median	0.34
	Standard Deviation	12.26
	Sample Variance	150.35
	Range	54.3474
	R-Value	(0.07)
	Mean Square Error	160.23
	R-Squared	0.01
	Significance	0.79
	Slope	(0.19)
	Total Sum of Squares	2,255

Xtant Book Value Per Share History

	2025	0.34
	2024	0.32
	2023	0.43
	2021	0.36
	2020	0.51
	2019	-3.36
	2018	-3.73

Other Fundumenentals of Xtant Medical Holdings

Tangible Book Value Per Share

Xtant Medical Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Current Deferred Revenue	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Net Tangible Assets	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital
Total Assets		0.07	0.69	-0.21	0.92	0.85	0.79	0.75	0.82	0.2	0.89	-0.43	0.71	0.88	0.87	-0.44	0.59	0.0	0.09	0.22	0.18
Total Stockholder Equity	0.07		-0.66	-0.32	-0.08	0.26	-0.52	0.41	-0.22	0.57	-0.01	-0.05	-0.64	-0.21	-0.27	0.82	-0.42	-0.72	0.57	0.11	0.57
Net Debt	0.69	-0.66		0.11	0.72	0.42	0.97	0.21	0.74	-0.23	0.71	-0.23	0.99	0.83	0.87	-0.93	0.73	0.54	-0.4	0.09	-0.33
Retained Earnings	-0.21	-0.32	0.11		-0.13	-0.46	-0.03	-0.7	-0.33	-0.53	0.17	0.52	0.05	-0.02	0.13	-0.4	0.05	0.85	-0.89	0.67	-0.71
Accounts Payable	0.92	-0.08	0.72	-0.13		0.82	0.82	0.67	0.75	0.08	0.8	-0.45	0.74	0.83	0.82	-0.51	0.58	0.15	-0.04	0.33	0.13
Net Receivables	0.85	0.26	0.42	-0.46	0.82		0.55	0.91	0.62	0.32	0.62	-0.5	0.44	0.62	0.54	-0.12	0.28	-0.27	0.4	0.13	0.52
Total Liab	0.79	-0.52	0.97	-0.03	0.82	0.55		0.36	0.83	-0.11	0.75	-0.35	0.98	0.89	0.9	-0.84	0.75	0.4	-0.29	0.1	-0.18
Total Current Assets	0.75	0.41	0.21	-0.7	0.67	0.91	0.36		0.6	0.39	0.42	-0.59	0.26	0.46	0.36	0.12	0.2	-0.55	0.68	-0.09	0.7
Current Deferred Revenue	0.82	-0.22	0.74	-0.33	0.75	0.62	0.83	0.6		0.12	0.62	-0.46	0.78	0.72	0.83	-0.55	0.82	0.02	0.1	0.0	0.07
Short Term Debt	0.2	0.57	-0.23	-0.53	0.08	0.32	-0.11	0.39	0.12		0.07	-0.12	-0.23	0.09	-0.01	0.45	-0.23	-0.67	0.56	-0.26	0.22
Intangible Assets	0.89	-0.01	0.71	0.17	0.8	0.62	0.75	0.42	0.62	0.07		-0.16	0.71	0.89	0.9	-0.56	0.56	0.28	-0.26	0.39	-0.13
Common Stock	-0.43	-0.05	-0.23	0.52	-0.45	-0.5	-0.35	-0.59	-0.46	-0.12	-0.16		-0.26	-0.31	-0.18	0.03	-0.17	0.27	-0.31	0.26	-0.23
Long Term Debt	0.71	-0.64	0.99	0.05	0.74	0.44	0.98	0.26	0.78	-0.23	0.71	-0.26		0.84	0.87	-0.91	0.76	0.49	-0.35	0.07	-0.26
Property Plant Equipment	0.88	-0.21	0.83	-0.02	0.83	0.62	0.89	0.46	0.72	0.09	0.89	-0.31	0.84		0.89	-0.65	0.51	0.26	-0.2	0.17	-0.07
Good Will	0.87	-0.27	0.87	0.13	0.82	0.54	0.9	0.36	0.83	-0.01	0.9	-0.18	0.87	0.89		-0.75	0.79	0.39	-0.31	0.33	-0.22
Net Tangible Assets	-0.44	0.82	-0.93	-0.4	-0.51	-0.12	-0.84	0.12	-0.55	0.45	-0.56	0.03	-0.91	-0.65	-0.75		-0.69	-0.78	0.64	-0.18	0.56
Short Long Term Debt	0.59	-0.42	0.73	0.05	0.58	0.28	0.75	0.2	0.82	-0.23	0.56	-0.17	0.76	0.51	0.79	-0.69		0.36	-0.26	0.18	-0.24
Long Term Debt Total	0.0	-0.72	0.54	0.85	0.15	-0.27	0.4	-0.55	0.02	-0.67	0.28	0.27	0.49	0.26	0.39	-0.78	0.36		-0.93	0.54	-0.72
Capital Surpluse	0.09	0.57	-0.4	-0.89	-0.04	0.4	-0.29	0.68	0.1	0.56	-0.26	-0.31	-0.35	-0.2	-0.31	0.64	-0.26	-0.93		-0.53	0.78
Net Invested Capital	0.22	0.11	0.09	0.67	0.33	0.13	0.1	-0.09	0.0	-0.26	0.39	0.26	0.07	0.17	0.33	-0.18	0.18	0.54	-0.53		-0.17
Net Working Capital	0.18	0.57	-0.33	-0.71	0.13	0.52	-0.18	0.7	0.07	0.22	-0.13	-0.23	-0.26	-0.07	-0.22	0.56	-0.24	-0.72	0.78	-0.17

Click cells to compare fundamentals

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	0.32	0.34
Tangible Book Value Per Share	0.20	0.21

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC